FDA and EMA Grant Orphan Drug Designation for Curadel’s CPI-008, a Targeted Zwitterionic Imaging Drug for Pancreatic Cancer

Curadel's novel targeted zwitterionic surgical imaging drug for pancreatic cancer has been granted Orphan Drug Designation by the FDA and the EMA.